Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell...

Area of Science:

• Molecular Biology
• Cell Biology
• Cardiovascular Research

Background:

• Vascular smooth muscle cell (VSMC) replication is crucial for intimal hyperplasia, a process implicated in cardiovascular diseases.
• Transcription factors c-myb and c-myc are key regulators of VSMC proliferation, rapidly induced by mitogenic stimuli and injury.
• Targeting c-myb and c-myc offers a potential strategy to prevent VSMC proliferation and associated vascular pathologies.

Purpose of the Study:

• To investigate the efficacy of dominant-negative gene constructs targeting c-myb and c-myc to inhibit VSMC proliferation.
• To explore the underlying mechanisms of VSMC proliferation inhibition, including apoptosis induction.
• To develop a targeted approach for delivering these inhibitory constructs specifically to VSMCs.

Main Methods:

• Designed dominant-negative gene constructs fusing c-myb or c-myc DNA-binding domains with the Drosophila engrailed repressor domain.
• Utilized transient transfection to introduce these constructs into rat, rabbit, and human VSMCs.
• Employed transcriptional regulatory elements from the human vascular smooth muscle alpha-actin gene for cell-specific targeting.

Main Results:

• Demonstrated a dramatic inhibition of VSMC proliferation lasting at least 72 hours post-transfection.
• Observed that the antiproliferative effect was, in part, mediated by the induction of apoptosis.
• Successfully achieved cell-specific targeting of VSMCs by coupling construct expression to the alpha-actin gene promoter.

Conclusions:

• Dominant-negative inhibition of c-myb and c-myc effectively suppresses VSMC proliferation.
• This approach holds promise for preventing intimal hyperplasia by reducing VSMC replication.
• Targeted delivery systems enhance the potential therapeutic application of these constructs in vascular smooth muscle cell-related diseases.